Living with polypharmacy: a narrative interview study with older Pakistanis in East London.


Journal

BMC geriatrics
ISSN: 1471-2318
Titre abrégé: BMC Geriatr
Pays: England
ID NLM: 100968548

Informations de publication

Date de publication:
15 Nov 2023
Historique:
received: 30 03 2023
accepted: 06 10 2023
medline: 17 11 2023
pubmed: 16 11 2023
entrez: 16 11 2023
Statut: epublish

Résumé

Polypharmacy is a growing and major public health issue. It can be burdensome and risky for patients and costly to healthcare systems. Older adults and those from ethnic minority backgrounds are disproportionately affected by polypharmacy. This study focuses on medication practices among Urdu-speaking Pakistani patients, a significant ethnic group in the UK. Most existing research on medication practices within South-Asian communities centres on adherence, leaving the social and moral dimensions of polypharmacy unpacked. Understanding how British Pakistani patients understand and manage polypharmacy in the context of their daily lives is crucial to avoiding harmful polypharmacy. In-depth narrative interviews were conducted with 15 first-generation Pakistani patients using the Biographical Narrative Interview Method. Participants were recruited from GP practices in East London. All participants were prescribed ten or more regular medications (a pragmatic marker of 'higher risk' polypharmacy) and were aged over 50. Interviews were conducted with a bilingual researcher at home and were designed to elicit narratives of patients' experiences of polypharmacy in the context of their biographies and daily lives. Polypharmacy is enacted through networks of interpersonal and socio-material relationships. The doctor-patient relationship and the family network held particular significance to study participants. In addition, participants described emotional bonds between themselves and their medicines, identifying them as 'forces for good'-substances which allowed them to maintain their health through the intercession of God. Meanings attributed to medicines and enacted through these social, emotional, and spiritual relationships contributed to emerging and sustaining polypharmacy. Patients make sense of and manage treatments in culturally specific ways. Developing an understanding of how medication practices in different communities are enacted is important for informing meaningful and effective conversations with patients about their medicines. Our findings contribute to enabling the integration of culturally sensitive approaches to prescribing.

Sections du résumé

BACKGROUND BACKGROUND
Polypharmacy is a growing and major public health issue. It can be burdensome and risky for patients and costly to healthcare systems. Older adults and those from ethnic minority backgrounds are disproportionately affected by polypharmacy. This study focuses on medication practices among Urdu-speaking Pakistani patients, a significant ethnic group in the UK. Most existing research on medication practices within South-Asian communities centres on adherence, leaving the social and moral dimensions of polypharmacy unpacked. Understanding how British Pakistani patients understand and manage polypharmacy in the context of their daily lives is crucial to avoiding harmful polypharmacy.
METHODS METHODS
In-depth narrative interviews were conducted with 15 first-generation Pakistani patients using the Biographical Narrative Interview Method. Participants were recruited from GP practices in East London. All participants were prescribed ten or more regular medications (a pragmatic marker of 'higher risk' polypharmacy) and were aged over 50. Interviews were conducted with a bilingual researcher at home and were designed to elicit narratives of patients' experiences of polypharmacy in the context of their biographies and daily lives.
RESULTS RESULTS
Polypharmacy is enacted through networks of interpersonal and socio-material relationships. The doctor-patient relationship and the family network held particular significance to study participants. In addition, participants described emotional bonds between themselves and their medicines, identifying them as 'forces for good'-substances which allowed them to maintain their health through the intercession of God. Meanings attributed to medicines and enacted through these social, emotional, and spiritual relationships contributed to emerging and sustaining polypharmacy.
CONCLUSIONS CONCLUSIONS
Patients make sense of and manage treatments in culturally specific ways. Developing an understanding of how medication practices in different communities are enacted is important for informing meaningful and effective conversations with patients about their medicines. Our findings contribute to enabling the integration of culturally sensitive approaches to prescribing.

Identifiants

pubmed: 37968631
doi: 10.1186/s12877-023-04392-1
pii: 10.1186/s12877-023-04392-1
pmc: PMC10652535
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

746

Subventions

Organisme : EPA
ID : EP-C-15-004
Pays : United States

Informations de copyright

© 2023. The Author(s).

Références

Pediatrics. 2004 May;113(5):e385-94
pubmed: 15121979
Br J Gen Pract. 1994 Apr;44(381):165-9
pubmed: 8185990
Br J Gen Pract. 2011 Sep;61(590):546-7
pubmed: 22152730
PLoS One. 2023 Feb 22;18(2):e0271650
pubmed: 36812177
Support Care Cancer. 2010 Feb;19(2):211-20
pubmed: 20076975
BMJ Open. 2013 Sep 13;3(9):e003610
pubmed: 24038011
Soc Sci Med. 2010 Mar;70(6):934-41
pubmed: 20096496
J Immigr Minor Health. 2022 Jun;24(3):682-688
pubmed: 34091799
Br J Gen Pract. 2017 Sep;67(662):388-389
pubmed: 28860279
Sci Rep. 2020 Nov 3;10(1):18964
pubmed: 33144598
Qual Saf Health Care. 2005 Dec;14(6):443-9
pubmed: 16326792
Qual Health Res. 2021 Sep;31(11):2111-2122
pubmed: 34110228
BMC Health Serv Res. 2014 Jun 26;14:281
pubmed: 24969758
Ann Fam Med. 2017 Jul;15(4):341-346
pubmed: 28694270
Ann Pharmacother. 2009 Feb;43(2):185-93
pubmed: 19193586
J Clin Pharm Ther. 2022 Sep;47(9):1322-1336
pubmed: 35844186
BMC Geriatr. 2022 Nov 7;22(1):841
pubmed: 36344918
Sociol Health Illn. 2008 Apr;30(3):429-44
pubmed: 18194358
Eur J Clin Pharmacol. 2011 Feb;67(2):193-201
pubmed: 21161197
BMC Geriatr. 2020 Jun 5;20(1):183
pubmed: 32498672
BMJ. 2012 Oct 04;345:e6341
pubmed: 23036829
BMC Geriatr. 2023 Mar 18;23(1):149
pubmed: 36934249
BMC Cardiovasc Disord. 2011 Sep 18;11:56
pubmed: 21923931
Hastings Cent Rep. 2000 Nov-Dec;30(6):28-37
pubmed: 11475993
Int J Clin Pharm. 2019 Feb;41(1):122-130
pubmed: 30564971
Int J Family Med. 2012;2012:193168
pubmed: 22900173
Br J Gen Pract. 2018 Apr;68(669):e245-e251
pubmed: 29530918
J Psychosom Res. 2008 Oct;65(4):311-7
pubmed: 18805239
Eur J Clin Pharmacol. 2010 Jul;66(7):735-42
pubmed: 20393695
Eur J Clin Pharmacol. 2012 Feb;68(2):171-8
pubmed: 21837393
Qual Health Res. 2020 Dec;30(14):2316-2330
pubmed: 32856537
Am J Emerg Med. 1996 Sep;14(5):447-50
pubmed: 8765105
Mayo Clin Proc. 2011 Apr;86(4):304-14
pubmed: 21389250
Int J Nurs Stud. 2014 Nov;51(11):1472-81
pubmed: 24647054
Lancet Public Health. 2020 Jan;5(1):e42-e50
pubmed: 31837974
BMC Geriatr. 2019 Mar 29;19(1):95
pubmed: 30925899

Auteurs

Najia Sultan (N)

Wolfson Institute of Population Health, Queen Mary University of London, London, UK. najia.sultan@qmul.ac.uk.

Deborah Swinglehurst (D)

Wolfson Institute of Population Health, Queen Mary University of London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH